The Latest Breaking News from Pfizer

Moderna is suing Pfizer and BioNTech for patent infringement, claiming the duo copied its mRNA technology. All three vaccine stocks fell.

COVID-19 vaccine maker Moderna is suing its main competitors Pfizer and the German drugmaker BioNTech, accusing the rivals of copying Moderna’s technology in order to make their own vaccine

Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound

Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults

Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound

LOS ANGELES — California schools reopened for the fall semester with loosened COVID-19 protocols and low student vaccination rates among younger children, presenting a new test for the trajectory of the pandemic as some experts expect another rise in cases when winter arrives.

Moderna stock inched higher late Tuesday just before announcing it asked the FDA to sign off on its updated Covid booster shot.

Pfizer’s says its COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 10 strange trades.